Skip to main content

Table 1 Patients Characteristics

From: Changes in treatment strategy over time for arteriovenous malformation in a Japanese high-volume center

 

(n = 154)

(n = 88)

(n = 242)

p value

First period

Second period

Total

No. of Pt.

 Gr. I n (%)

29 (18.8)

13 (18.8)

42 (17.4)

0.483

 Gr. II n (%)

46 (29.9)

33 (37.5)

79 (32.6)

0.255

 Gr. III n (%)

39 (25.3)

22 (25.0)

61 (25.2)

1.000

 Gr. IV n (%)

31 (20.1)

14 (15.9)

45 (18.6)

0.493

 Gr. V n (%)

9 (5.8)

6 (6.8)

15 (6.2)

0.786

Age

33.1 ± 16.3

33.3 ± 17.5

 

0.219

Sex(M, F)

82, 72

46, 42

128, 114

0.894

Onset n (%)

 Hemorrhage

78 (50.6)

36 (40.9)

114 (47.1)

0.181

 Seizure

30 (19.5)

17 (19.3)

47 (19.4)

1.000

 Incidental

21 (13.6)

14 (15.9)

35 (14.5)

0.705

 Headache

18 (11.7)

18 (20.5)

36 (14.9)

0.090

 Cranial nerve palsy

4 (2.6)

2 (2.3)

6 (2.5)

1.000

 other

3 (1.9)

1 (1.1)

4 (1.7)

1.000

Interventional cases (%)

 Gr. I

24 (82.8)

13 (100)

37 (88.1)

0.302

 Gr. II

43 (93.5)

28 (84.8)

71 (89.9)

0.268

 Gr. III

30 (76.9)

14 (63.6)

44 (72.1)

0.373

 Gr. IV

10 (32.3)

4 (28.6)

14 (31.1)

1.000

 Gr.V

2 (22.2)

1 (16.7)

3 (20.0)

1.000

 

109

60

169

0.666

Treatment n (%)

 surgery (S) only

73 (47.4)

11 (12.5)

84 (34.7)

< 0.001

 S + embolization (E)

18 (11.7)

23 (26.1)

41 (16.9)

0.007

 S + radiation (R)

6 (3.9)

4 (4.5)

10 (4.1)

1.000

 S + E + R

1 (0.6)

1 (1.1)

2 (0.8)

1.000

 R only

8 (5.2)

14 (15.9)

22 (9.1)

0.009

 E + R

1 (0.6)

4 (4.5)

5 (2.1)

0.060

 E only

2 (1.3)

3 (3.4)

5 (2.1)

0.357

 medical

45 (29.2)

28 (31.8)

73 (30.2)

0.673

 include surgery

98 (63.6)

39 (44.3)

137 (56.6)

0.005

 include radiation

16 (10.4)

23 (26.1)

39 (16.1)

0.002

 mortbidity, n (%)

1 (0.92)

0 (0)

1 (0.59)

1.000

 mortality, n (%)

1 (0.92)

1 (1.67)

2 (1.18)

1.000

  1. Baseline characteristics of patients with AVMs and the proportion of each treatment for each S–M grade during the first and second periods of our study